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Utility of Xpert ® MTB/RIF in the Diagnosis of Extrapulmonary Tuberculosis
Respected Editor, In most studies on Xpert ® MTB/RIF assay in extrapulmonary tuberculosis (EPTB), it has usually been compared to culture, which is known to be a suboptimal reference standard for EPTB. [1, 2] We share the results of our retrospective study on patients ≥18 years with suspected EPTB between January and July 2015, in which we compared Xpert ® MTB/RIF to a composite reference standard (CRS). Patients with proven alternate diagnosis, those with incomplete records and who died or were lost to follow-up within 3 months of starting antituberculous therapy (ATT) were excluded from the study. The patients were classified based on CRS as follows: confirmed TB (microbiologically confirmed), probable TB (clinical symptoms, radiological findings and/or histology/cytology suggestive of TB, no microbiological evidence), possible TB (follow-up indicated response to empirical ATT after 3 months) and not TB (proven alternate diagnoses).
After exclusion, 225 (75 confirmed and 150 probable) of 752 patients with EPTB were included in the study analysis [ Figure 1 ]. Samples included pus (31, 13%), tissue (144, 61%), fluids (40, 17%) and cerebrospinal fluid (20, 8.5%). The rates of culture and Xpert ® MTB/RIF positivity in different samples are depicted in Table 1 . Xpert ® MTB/RIF was positive in 68.5%, smear in 11.2% and culture in 35.6% of the cases.
Xpert ® MTB/RIF had better sensitivity than cultures for all body sites, especially for lymph node and osteo-articular TB. It had greater sensitivity in tissues than fluids in the diagnosis of pleural and abdominal TB (74% vs. 22%). In all patients with alternate diagnoses, Xpert ® MTB/RIF assay was negative. The sensitivity of Xpert ® MTB/RIF to identify rifampicin resistance was 100% but specificity was 84.5%.
In conclusion, Xpert ® MTB/RIF assay detected >2/3 rd of EPTB cases, was 100% specific and almost twice as sensitive as mycobacterial culture. Our findings support the WHO recommendations to routinely use Xpert ® MTB/RIF assay in the diagnosis of EPTB. [3] Financial support and sponsorship Nil.
Abstract
Case Report
IntroductIon
A patient on antitubercular therapy (ATT) can have worsening of his condition after an initial improvement termed as a paradoxical upgradation response. These reactions may be wrongly diagnosed as drug resistance, treatment failure or a superadded infection. Less is known about the exact mechanism of paradoxical upgradation responses. The development of paradoxical response in pulmonary tuberculosis (PTB) is rare compared to extrapulmonary TB (EPTB). In PTB, paradoxical reaction develops on the ipsilateral side of lung lesion and it is rare on the contralateral side. We report two unusual cases of paradoxical reactions: one in PTB and the other in EPTB.
case reports
Case 1
A 34-year-old male, medical professional, presented with complaints of fever with sore throat for 6 days and cough for 3 days with generalised weakness. The patient was given symptomatic treatment, but he had persistent cough so was advised chest X-ray (CXR), sputum gram stain, acid-fast bacillus (AFB) stain and culture. CXR showed prominent left hilum with a possibility of enlarged lymph nodes, so contrast-enhanced computed tomography (CECT) chest was done which showed multiple discrete and confluent necrotic lymph nodes in the right paratracheal, bilateral tracheobronchial, subcarinal, left para-aortic and left hilar regions. The largest confluent lymph node was seen in the left hilar region measuring nearly 3.4 cm × 2.4 cm, multiple opacities noted in the apical segment of the left lung lower lobe likely tubercular aetiology [ Figure 1a , d, g and j]. Sputum AFB was positive, and he was started on ATT with four drugs Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E). GeneXpert for Mycobacterium tuberculosis (MTB) revealed MTB (detected very low), and rifampicin resistance was not detected. The patient clinically improved after initiation of ATT. AFB culture and sensitivity revealed MTB sensitive to first-line drugs.
After 2 months, the patient again presented with worsening cough, sore throat and anorexia. The patient's compliance with ATT was good and HIV status was negative. A repeat sputum sample was sent for AFB stain and culture, and he A paradoxical upgradation response in tuberculosis (TB) is defined as the worsening of a pre-existing tubercular lesion or the appearance of a new lesion in a patient whose clinical symptoms initially improved with anti-TB treatment. A paradoxical response is common in HIV patients in the form of immune reconstitution inflammatory syndrome. A similar kind of response can also be seen in immunocompetent patients. Here, we present two cases of non-HIV TB who initially improved with antitubercular therapy (ATT) but worsened thereafter. After excluding possibilities such as multidrug-resistant TB, treatment failure or a superadded infection, a paradoxical upgradation response was diagnosed. Both the cases improved after treatment with corticosteroids in addition to ATT.
